Literature DB >> 20835992

Adenosine-to-inosine RNA editing.

Boris Zinshteyn1, Kazuko Nishikura1.   

Abstract

Ribonucleic acid (RNA) editing is a mechanism that generates RNA and protein diversity, which is not directly encoded in the genome. The most common type of RNA editing in vertebrates is the conversion of adenosine to inosine in double-stranded RNA which occurs in the higher eukaryotes. This editing is carried out by the family of adenosine deaminase acting on RNA (ADAR) proteins. The most-studied substrates of ADAR proteins undergo editing which is very consistent, highly conserved, and functionally important. However, editing causes changes in protein-coding regions only at a small proportion of all editing sites. The vast majority of editing sites are in noncoding sequences. This includes microRNAs, as well as the introns and 3' untranslated regions of messenger RNAs, which play important roles in the RNA-mediated regulation of gene expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20835992      PMCID: PMC2946787          DOI: 10.1002/wsbm.10

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Syst Biol Med        ISSN: 1939-005X


  57 in total

1.  The RNA world meets behavior: A-->I pre-mRNA editing in animals.

Authors:  R A Reenan
Journal:  Trends Genet       Date:  2001-02       Impact factor: 11.639

2.  Specific cleavage of hyper-edited dsRNAs.

Authors:  A D Scadden; C W Smith
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

Review 3.  RNA editing by base deamination: more enzymes, more targets, new mysteries.

Authors:  A P Gerber; W Keller
Journal:  Trends Biochem Sci       Date:  2001-06       Impact factor: 13.807

Review 4.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

5.  A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.

Authors:  C X Chen; D S Cho; Q Wang; F Lai; K C Carter; K Nishikura
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

Review 6.  A-to-I RNA editing: recent news and residual mysteries.

Authors:  Stefan Maas; Alexander Rich; Kazuko Nishikura
Journal:  J Biol Chem       Date:  2002-11-20       Impact factor: 5.157

7.  Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA.

Authors:  B L Bass; H Weintraub; R Cattaneo; M A Billeter
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

8.  Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.

Authors:  K A Lehmann; B L Bass
Journal:  Biochemistry       Date:  2000-10-24       Impact factor: 3.162

9.  RNAi is antagonized by A-->I hyper-editing.

Authors:  A D Scadden; C W Smith
Journal:  EMBO Rep       Date:  2001-11-21       Impact factor: 8.807

10.  RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA.

Authors:  Daniel P Morse; P Joseph Aruscavage; Brenda L Bass
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

View more
  39 in total

Review 1.  Detecting RNA modifications in the epitranscriptome: predict and validate.

Authors:  Mark Helm; Yuri Motorin
Journal:  Nat Rev Genet       Date:  2017-02-20       Impact factor: 53.242

Review 2.  ADAR editing in double-stranded UTRs and other noncoding RNA sequences.

Authors:  Heather A Hundley; Brenda L Bass
Journal:  Trends Biochem Sci       Date:  2010-04-08       Impact factor: 13.807

Review 3.  Non-coding RNA networks in cancer.

Authors:  Eleni Anastasiadou; Leni S Jacob; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2017-11-24       Impact factor: 60.716

Review 4.  Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders.

Authors:  Richard T O'Neil; Ronald B Emeson
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

5.  Cell lineage inference from SNP and scRNA-Seq data.

Authors:  Jun Ding; Chieh Lin; Ziv Bar-Joseph
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

Review 6.  Nucleoside analogs in the study of the epitranscriptome.

Authors:  Cody M Palumbo; Peter A Beal
Journal:  Methods       Date:  2018-10-26       Impact factor: 3.608

7.  In vitro screening for drug-induced depression and/or suicidal adverse effects: a new toxicogenomic assay based on CE-SSCP analysis of HTR2C mRNA editing in SH-SY5Y cells.

Authors:  Laurent Cavarec; Laurent Vincent; Claudia Le Borgne; Camille Plusquellec; Nathalie Ollivier; Priscilla Normandie-Levi; Frédéric Allemand; Nicolas Salvetat; Eve Mathieu-Dupas; Franck Molina; Dinah Weissmann; Jean-François Pujol
Journal:  Neurotox Res       Date:  2012-04-13       Impact factor: 3.911

8.  MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.

Authors:  Yael Nemlich; Eyal Greenberg; Rona Ortenberg; Michal J Besser; Iris Barshack; Jasmine Jacob-Hirsch; Elad Jacoby; Eran Eyal; Ludmila Rivkin; Victor G Prieto; Nitin Chakravarti; Lyn M Duncan; David M Kallenberg; Eitan Galun; Dorothy C Bennett; Ninette Amariglio; Menashe Bar-Eli; Jacob Schachter; Gideon Rechavi; Gal Markel
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

9.  Effects of ADARs on small RNA processing pathways in C. elegans.

Authors:  M Bryan Warf; Brent A Shepherd; W Evan Johnson; Brenda L Bass
Journal:  Genome Res       Date:  2012-06-06       Impact factor: 9.043

10.  Reprogramming of microRNAs by adenosine-to-inosine editing and the selective elimination of edited microRNA precursors in mouse oocytes and preimplantation embryos.

Authors:  Jesús García-López; Juan de Dios Hourcade; Jesús Del Mazo
Journal:  Nucleic Acids Res       Date:  2013-04-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.